| EVOTEC SE INH O.N. |
| Deutschland |
| Gesundheit |
| DE0005664809 / 566480 |
| EVT (Frankfurt) |
| FRA:EVT, ETR:EVT, EVT:GR |
| https://www.evotec.com/ |
|
Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two key segments: EVT Execute, which delivers integrate..
>Volltext.. |
| 970.14 Mio. EUR |
| 941.32 Mio. EUR |
| 788.82 Mio. EUR |
| 0.22 Mio. EUR |
| -103.58 Mio. EUR |
| -0.58 EUR |
| 447.94 Mio. EUR |
| 418.75 Mio. EUR |
| -9.44 Mio. EUR |
| 1.29 |
| -1.08% |
| 47.21% |
| - |
| - |
| - |
| - |
| EVOTEC |
| 24.04.26 |
|
||||
|